Wird geladen...
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial
BACKGROUND AND OBJECTIVES: Minimal change disease is an important cause of nephrotic syndrome in adults. Corticosteroids are first-line therapy for minimal change disease, but a prolonged course of treatment is often required and relapse rates are high. Patients with minimal change disease are there...
Gespeichert in:
Veröffentlicht in: | Clin J Am Soc Nephrol |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
American Society of Nephrology
2020
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015084/ https://ncbi.nlm.nih.gov/pubmed/31953303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06180519 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|